The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet
- PMID: 6705274
The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet
Abstract
The rate of progression of renal failure has been evaluated in two homogenous groups of chronic renal patients with early insufficiency. In both groups the diet supplied the same amount of calories (approximately 35 Kcal/kg/day) and the protein intake was equally restricted (approximately, 0.6 g/kg/day); however, in Group 1 the phosphorus intake was lower (6.5 mg/kg/day) than in Group 2 (12 mg/kg/day). In both groups the rate of decline of creatinine clearance decreased when patients changed from a free mixed diet to the specially controlled diets, but in Group 1 (lower phosphorus intake) this change was much more marked than in Group 2. Elevated mean levels of serum phosphate and of urinary output of phosphate per unit of creatinine clearance, and elevated mean levels of serum iPTH were found in the patients of Group 2, whereas Group 1 patients had normal mean levels of serum phosphate and of iPTH, and the phosphaturia per unit of creatinine clearance was almost normal. The role of such abnormalities in urinary and serum phosphate, and of secondary hyperparathyroidism, on the progression of renal failure is discussed.
Similar articles
-
Restricted phosphorus and nitrogen intake to slow the progression of chronic renal failure: a controlled trial.Kidney Int Suppl. 1983 Dec;16:S278-84. Kidney Int Suppl. 1983. PMID: 6376918 Clinical Trial.
-
Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial.Q J Med. 1991 Oct;81(294):837-55. Q J Med. 1991. PMID: 1801057 Clinical Trial.
-
Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure.Kidney Int Suppl. 1983 Dec;16:S273-7. Kidney Int Suppl. 1983. PMID: 6588264
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Dietary manipulation and progression of chronic renal failure.Child Nephrol Urol. 1991;11(3):134-9. Child Nephrol Urol. 1991. PMID: 1777891 Review.
Cited by
-
Optimising nutrition in chronic renal insufficiency--progression of disease.Pediatr Nephrol. 2004 Nov;19(11):1253-61. doi: 10.1007/s00467-004-1581-2. Pediatr Nephrol. 2004. PMID: 15349763
-
Diabetic nephropathy: Time to withhold development and progression - A review.J Adv Res. 2017 Jul;8(4):363-373. doi: 10.1016/j.jare.2017.04.004. Epub 2017 Apr 21. J Adv Res. 2017. PMID: 28540086 Free PMC article. Review.
-
Stop chronic kidney disease progression: Time is approaching.World J Nephrol. 2016 May 6;5(3):258-73. doi: 10.5527/wjn.v5.i3.258. World J Nephrol. 2016. PMID: 27152262 Free PMC article. Review.
-
Controlled low protein diets in chronic renal insufficiency: meta-analysis.BMJ. 1992 Jan 25;304(6821):216-20. doi: 10.1136/bmj.304.6821.216. BMJ. 1992. PMID: 1531426 Free PMC article.
-
Effect of protein restriction in insulin dependent diabetics at risk of nephropathy.Br Med J (Clin Res Ed). 1987 Mar 28;294(6575):795-8. doi: 10.1136/bmj.294.6575.795. Br Med J (Clin Res Ed). 1987. PMID: 3105747 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Medical